% | $
Quotes you view appear here for quick access.

Regenerx Biopharmaceuticals Inc. Message Board

  • snogreen snogreen Apr 13, 2011 12:35 PM Flag

    From Allergan:

    This from Allergan on RESTASIS:

    <<Research has shown that chronic dry eye occurs when changes to the health of the tear-producing glands affect the quantity and quality of tears produced.... ... Dry eye affects an estimated 21 million people in the United States1 and can be a progressive disease. If left untreated, chronic dry eye can lead to more serious problems. RESTASIS® ophthalmic emulsion is the first, and currently the only, prescription eye drop that helps to increase your eyes' natural ability to produce tears which may be suppressed by inflammation due to chronic dry eye. RESTASIS® ophthalmic emulsion did not increase tear production in patients using topical steroid drops or tear duct plugs. ... RESTASIS®, approved by the U.S. Food and Drug Administration in 2002, is currently the only prescription eye drop believed to address an underlying cause of chronic dry eye.>>>

    They say a couple times it is "the only" approved therapy.....Someone send Allergan the results from Ora, inc with TB 4 against RESTASIS in mice! Lord knows << Finkle-Tinkle- Twinkle >>.... won't.

    I see we are up to.....what...EIGHT 5,000 share blocks puked on downticks so far today? When will Lincoln Capital be clean? I am sure it's them. And when will Finklestin buy 1,000 shares ($180 worth) 18 cents???

    HAHA! Never.

0.379-0.001(-0.26%)Sep 26 3:56 PMEDT